For patients with stages I-IIIA invasive breast cancer
For patients with stages I-IIIA invasive breast cancer, learn about the only genomic test proven to predict whether you are likely to benefit from chemotherapy. Plus, get an understanding of the testing process, learn what you can expect from the test results, watch patient stories, explore FAQs, and more.
Coree used the Breast Recurrence Score® results to help her choose the most appropriate treatment for her invasive breast cancer. Hear her story.
Learn about the genomic test that quantifies the risk of local recurrence for patients with early-stage non-invasive ductal carcinoma in situ (DCIS). Plus, get an understanding of the testing process, learn what you can expect from the test results, watch patient stories, explore FAQs, and more.
Jen used her DCIS Score® result to confirm her treatment decision for her early-stage cancer. Hear Jen’s story.
